Preclinical investigations that subserve efforts to employ bone marrow transplantation for rheumatoid or autoimmune diseases

Journal of Rheumatology

Volumn 24, Issue SUPPL. 48, 1997, Pages 5-12

  Good, Robert A ^a,c   Ikehara, Susumu ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

Author keywords

Animal models; Autoimmunity; Bone marrow transplant; SCID

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ALLOTRANSPLANTATION; ANIMAL; AUTOIMMUNE DISEASE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHICK EMBRYO; COMBINED IMMUNODEFICIENCY; DISEASE MODEL; DOG; FEMALE; HUMAN; IMMUNE DEFICIENCY; MALE; METHODOLOGY; MIDDLE AGED; MOUSE; PATHOPHYSIOLOGY; REVIEW; RHEUMATIC DISEASE; TREATMENT OUTCOME; WISKOTT ALDRICH SYNDROME; ANIMAL MODEL; AUTOIMMUNITY; BONE TRANSPLANTATION; CONFERENCE PAPER; DEMYELINATING DISEASE; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PREVENTION; PRIORITY JOURNAL; RECURRENT DISEASE; STEM CELL; SURGERY; THERAPY; THYMUS TRANSPLANTATION;

ANIMALS; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; CHICK EMBRYO; DISEASE MODELS, ANIMAL; DOGS; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MICE; MIDDLE AGED; RHEUMATIC DISEASES; SEVERE COMBINED IMMUNODEFICIENCY; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; WISKOTT-ALDRICH SYNDROME;

EID: 0030956057     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Cooper MD, Perey DY, Peterson RDA, Gabrielsen AE, Good RA: The two-component concept of the lymphoid system. In: Bergsma D, Good RA, eds. The Immunologic Deficiency Diseases in Man. New York: The National Foundation, 1968:7-16.
2. Good RA, Peterson RDA, Perey DY, Finstad J, Cooper MD: The immunological deficiency diseases of man: Consideration of some questions asked by these patients with an attempt at classification. In: Bergsma D, Good RA, eds. Immunologic Deficiency Diseases in Man. New York: The National Foundation, 1968:17-39.
3. Good RA: Disorders of the immune system. In: Good RA, Fisher DW, eds. Immunobiology. Massachusetts: Sinauer Associates, 1971:3-16.
4. Archer OK, Pierce JC: Role of the thymus in development of the immune response. Fed Proc 1961;20:26.
5. Miller JFAP: Immunological function of the thymus. Lancet 1961;2:748-9.
6. Good RA, Dalmasso AP, Martinez C, Archer OK, Pierce JC, Papermaster BW: The role of the thymus in development of immunologic capacity in rabbits and mice. J Exp Med 1962;116:773-96.
7. Glick B, Chang TS, Jaap RG: The bursa of Fabricius and antibody production. Poult Sci 1956;35:224-5.
8. Good RA, Gabrielsen AE, Cooper MD, Peterson RDA: The role of the thymus and bursa of Fabricius in the development of effector mechanisms. Ann NY Acad Sci 1966;129:130-54.
9. Cooper MD, Peterson RDA, Good RA: Delineation of the thymic and bursal lymphoid systems in the chicken. Nature 1965;205:143-6.
10. Peterson RDA, Cooper MD, Good RA: The pathogenesis of immunologic deficiency diseases. Am J Med 1965;38:579-604.
11. Hoyer R, Cooper MD, Gabrielsen AE, Good RA: Lymphopenic forms of congenital immunologic deficiency: Clinical and pathologic patterns. In: Bergsma D, Good RA, eds. Immunologic Deficiency Diseases in Man. New York: The National Foundation, 1968:91-103.
12. Trentin JJ: The immunological basis for induced tolerance to skin homografts in irradiated mice receiving bone marrow transfusions. Transplant Bull 1957;4:74.
13. Lorenz E, Uphoff D, Reid TR, Shelton E: Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 1951;12:197-201.
14. Storb R, Thomas ED: Bone marrow transplantation in randomly bred animal species and in man. In: Schwarz MR, ed. Proceedings of the Sixth Leucocyte Culture Conference. New York: Academic Press, 1972:805-40.
15. Thomas ED, LeBlond R, Graham TC, Storb R: Marrow infusions in dogs given midlethal or lethal irradiation. Radiat Res 1970;41:113-24.
16. Storb R, Epstein RB, Rudolph RH, Thomas ED: The effect of prior transfusion on marrow grafts between histocompatible canine siblings. J Immunol 1970;105:627-33.
17. 1 hybrid effect. J Natl Cancer Inst 1957;19:123-30.
18. Main JM, Prehn RT: Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. J Natl Cancer Inst 1955;15:1023-9.
19. Epstein RB, Storb R, Ragde H, Thomas ED: Cytotoxic typing antisera for marrow grafting in littermate dogs. Transplantation 1968;6:45-58.
20. Storb R, Epstein RB, Graham TC, Thomas ED: Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 1970;9:240-6.
21. Gatti RA, Meuwissen HF, Allen HD, Hong R, Good RA: Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968;2:1366-9.
22. Good RA, Gatti RA, Hong R, Meuwissen HJ: Graft treatment of immunological deficiency (letter). Lancet 1969;1:1162.
23. Good RA, Gatti RA, Hong R, Meuwissen HJ: Successful marrow transplantation for correction of immunological deficit in lymphopenic agammaglobulinemia and treatment of immunologically induced pancytopenia. Exp Hematol 1969;19:4-10.
24. Good RA: Immunologic reconstitution: The achievement and its meaning. Hosp Pract 1909,4:41-7.
25. Good RA: Organization and development of the immune system: Relation to its reconstruction. In: Sackstein R, Janssen WE, Elfenbein GJ, eds. Bone Marrow Transplantation Foundations for the 21st Century. New York: Ann N Y Acad Sci 1995;770:8-31.
26. Bortin MM, Bach FH, van Bekkum DW, Good RA, van Rood JJ: 25th anniversary of the first successful allogeneic bone marrow transplants. Bone Marrow Transplant 1994;14:211-2.
27. Bach FH, Albertini RJ, Joo P, Anderson JLY, Bortin MM: Bone marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 1968;1:1364-6.
28. De Koning J, Van Bekkum DW, Dicke KA, Dooren LJ, Radl J, Van Rood JJ: Transplantation of bone marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency. Lancet 1969;1:1223-7.
29. Thomas ED, Buckner CD, Banaji M, et al: One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 1977;49:511-33.
30. Mathe G, Schwarzenberg L, Kiger N, Florentin I, Halle-Pannenko O, Garcia-Giralt A: Bone marrow transplantation for aplasias and leukemias. In: Bach FH, Good RA, eds. Clinical Immunology, vol 2. New York: Academic Press, 1974:33-62.
31. Thomas ED, Storb R, Clift RA, et al: Bone marrow transplantation (First of Two Parts). N Engl J Med 1975;292:832-43.
32. Thomas ED, Storb R, Clift R, et al: Bone marrow transplantation. II. N Engl J Med 1975;292:895-902.
33. Thomas ED, Buckner CD, Clift RA, et al: Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 1979;301:597-9.
34. Kapoor N, Good RA: Bone marrow transplantation in 1985. In: Aiuti F, Rosen F, Cooper MD, eds. Recent Advances in Primary and Acquired Immunodeficiencies. New York: Raven Press, 1986:327-81.
35. Buckley RH: Transplantation. In: Stiehm ER, ed. Immunological Disorders in Infants and Children, 4th ed. Philadelphia: W.B. Saunders, 1995:1014-58.
36. Schiff R: Bone marrow transplantation for immune deficiency disorders. The Molecular Basis of Immune Deficiency Disorders and Strategies for Therapy Meeting: West Palm Beach, 1994. Bone marrow transplantation for primary immunodeficiency diseases - summary of the world's experience. Meeting abstracts book.
37. Ikehara S, Good RA, Nakamura T, et al: Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci USA 1985;82:2483-7.
38. Ikehara S, Yasumizu R, Inaba M, et al: Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1989;86:3306-10.
39. Himeno K, Good RA: Marrow transplantation from tolerant donors to treat and prevent autoimmune diseases in BXSB mice. Proc Natl Acad Sci USA 1988;85:2235-9.
40. Ikehara S, Ohtsuki H, Good RA, et al: Prevention of type I diabetes in non-obese diabetic mice by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1985;82:7743-7.
41. Yasumizu R, Sugiura K, Iwai H, et al: Treatment of type I diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proc Natl Acad Sci USA 1987;84:6555-7.
42. Oyaizu N, Yasumizu R, Miyama-Inaba M, et al: (NZWxBXSB)F mouse, a new animal model of idiopathic thrombocytopenic purpura. J Exp Med 1988;167:2017-22.
43. Mizutani H, Engelman RW, Kurata Y, Ikehara S, Good RA: Development and characterization of monoclonal antiplatelet autoantibodies from autoimmune thrombocytopenic purpura-prone (NZW x BXSB)F, mice. Blood 1993;82:837-44.
44. 1 mice by haploidentical bone marrow transplantation: Possible role for anticardiolipin autoantibodies. Blood 1993;82:3091-7.
45. 1 mice: Association with anticardiolipin autoantibodies. Proc Soc Exp Biol and Med 1995;209:219-85.
46. 1 autoimmune-prone mice by bone marrow transplantation (dissertation). Tampa, Florida: University of South Florida, 1995.
47. Ikehara S, Kawamura M, Takao F, et al: Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990;87:8341-4.
48. Sardiña EE, Sugiura K, Ikehara S, Good RA: Transplantation of WGA+ hematopoietic cells to prevent or induce systemic autoimmune disease. Proc Natl Acad Sci USA 1991;88:3218-22.
49. Ahmed H: Bone marrow transplantation and dietary manipulation as approaches to the prevention and treatment of autoimmune disease in MRL mice (dissertation). Tampa, Florida: University of South Florida, 1992.
50. Ikehara S, Inaba M, Ishida S, et al: Rationale for transplantation of both allogeneic bone marrow and stromal cells in the treatment of autoimmune diseases. In: Champlin RE, Gale RP, eds. New Strategies in Bone Marrow Transplantation. New York: Wiley-Liss, 1991:251-7.
51. Ishida T, Inaba M, Hisha H, et al: Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation: Complete prevention of recurrence of autoimmune diseases in MRL/lpr mice by transplantation of bone marrow plus bone (stromal cells) from the same donor. J Immunol 1994;152:3119-21.
52. Ikehara S, Inaba M, Yasumizu R, et al: Autoimmune diseases as stem cell disorders. Tohoku J Exp Med 1994;173:141-55.
53. Ikehara S, Tanaka H, Nakamura T, et al: The influence of thymic abnormalities on the development of autoimmune diseases. Thymus 1985;1:25-36.
54. Nakamura T, Ikehara S, Good RA, et al: Abnormal stem cells in autoimmune-prone mice are responsible for premature thymic involution. Thymus 1985;7:151-60.
55. Nakamura T, Good RA, Yasumizu R, et al: Successful liver allografts in mice by combination with allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1986;83:4529-32.
56. Onoé K, Fernandes G, Good RA: Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J Exp Med 1980;151:115-32.
57. Onoé K, Yasumizu R, Oh-ishi T, Kakinuma M, Good RA, Morikawa K: Restricted antibody formation to sheep erythrocytes of allogeneic bone marrow chimeras histoincompatible at the K end of the H-2 complex. J Exp Med 1981;153:1009-14.
58. Krown SE, Coico R, Scheid MP, Fernandes G, Good RA: Immune function in fully allogeneic mouse bone marrow chimeras. Clin Immunol Immunopathol 1981;19:268-83.
59. Coico R, Krown SE, Good RA, Hoffmann MK: Helper cell factors restore antibody responses of allogeneic bone marrow chimeras: Evidence for ineffective cellular interactions. J Immunol 1982;128:1590-3.
60. Nakamura T, Good RA, Yasumizu R, Inoue S, Oo MM, Hamashima Y, Ikehara S: Successful liver allografts in mice by combination with allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1985;83:4529-32.
61. Sugiura K, Yasumizu R, Iwai H, et al: Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibilily barriers: Persistent or redeveloping immunologic responsiveness after prolonged survival. Thymus 1991;18:137-53.
62. Hisha H, Nishino T, Kawamura M, Adachi S, Ikehara S: Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp Hematol 1995;23:347-52.
63. Than S, Ishida H, Inaba M, et al: Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. J Exp Med 1992;176:1233-7.
64. Reisner Y, Itzicovitch L, Meshorer A, Sharon N: Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. Proc Natl Acad Sci USA 1975;75:2933-6.
65. Reisner Y, Kapoor N, Hodes MZ, O'Reilly RJ, Good RA: Enrichment for cFU-C from murine and human bone marrow using soybean agglutinin. Blood 1982;59:360-3.
66. Reisner Y, Kapoor N, Kirkpatrick D, et al: Transplantation for severe combined immunodeficiency with HLA-A, B, D, Dr incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983;461:341-8.
67. Reisner Y, Kapoor N, Kirkpatrick D, et al: Transplantation for acute leukemia using HLA-A and B non-identical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 1981;2:321-31.
68. Buckley RH, Schiff SE, Sampson HA, et al: Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 1986;136:2398-407.
69. O'Reilly RJ, Kernan NA, Cunningham I, et al: Allogeneic transplants depleted of T cells by soybean lectin agglutination and E-rosette depletion. Bone Marrow Transplant 1988;(suppl 1)3:3-6.
70. Aversa F, Tabilio A, Terenzi A, et al: Successful engraftment of T-cell depleted haploidentical "three loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994;84:3948-55.
71. Ishii E, Gengozian N, Good RA: Influence of dimethyl myleran on tolerance induction and immune function in major histocompatibility complex-haploidentical murine bone-marrow transplantation. Proc Natl Acad Sci USA 1991;88:8435-9.
72. Hosaka N, Nose M, Kyogoku M, et al: Aging of the thymus is a critical factor in successful bone marrow transplantation. Bone marrow transplantation plus fetal thymus grafts is a strategy for treatment of autoimmune diseases in old MRL/+ mice. Proc Natl Acad Sci USA 1990;93:8558-62.
73. van Bekkum DW: BMT in experimental autoimmune diseases. Bone Marrow Transplant 1993;11:183-7.